Investor Calendar is powered by PrecisionIR, the leading webcaster of official investor relations events, and offers free access to live and archived corporate communications
December 11, 2002 - 8:00 AM Eastern
VaxGen Educational Symposium
Information contained in this webcast is current as of the date and time first presented. The use of pop-up blocking or firewall software may prevent you from accessing this webcast. Please temporarily disable any of these products you may have while attempting to access this event.
About The Company
VaxGen, Inc. (Nasdaq: VXGN - News) is a biopharmaceutical company engaged in the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. Based in Brisbane, Calif., the company is developing preventive vaccines against anthrax, smallpox and HIV and is the largest shareholder in Celltrion, Inc., a joint venture formed to build biopharmaceutical manufacturing operations for the manufacture of biopharmaceutical products, including those from VaxGen, should they be licensed. Celltrion is funded by a consortium of South Korean investors, with VaxGen contributing manufacturing technology, know-how and training. For more information, please visit the company's web site at: www.vaxgen.com.
A part of PrecisionIR Group, www.PrecisionIR.com
601 Moorefield Park Drive, Richmond, VA 23236
145 Cannon Street, London, EC4N 5BQ, UK (Registered in England No 2394368)
Strandvägen 7A, 114 56 Stockholm, Sweden